LogoLogo
  • About Us
    • About Aurobindo
    • Vision / Mission
    • Milestones
    • R&D
    • Manufacturing
    • Management
      • Board of Directors
    • Our Presence
  • Our Business
    • APUSA
    • Europe
    • Growth Markets
    • ARV
      • Overview
      • Key facts about HIV/AIDS
      • Products
      • Global Partners
      • Gallery
      • Corporate Video
    • Apitoria (API)
    • Eugia (Speciality products)
    • Curateq (Biosimilars) / Peptide
  • Sustainability
    • ESG / Sustainability
      • ESG Profile
      • Sustainability Reports
      • BMW Reports
    • Social Accountability Standards
      • Social Compliance Certification
      • Sustainability of Social Accountability Standards
      • Human Rights Policy
      • Progressive Health and Safety Practices
      • Community Impact
      • Supply Chain Management
      • Supplier Code of Conduct
    • CSR
      • Aurobindo Pharma Foundation
      • CSR Policy
      • Annual Report
      • Gallery
      • Annual Action Plan
      • Impact Assessment Reports - CSR Projects
    • Access to Healthcare
      • PEPFAR program
  • Investors
    • Results, Reports & Presentations
      • Results Announcements
      • Annual Reports
      • Financials - Subsidiaries
      • Related Party Transactions
    • Shareholder Information
      • Shareholding Pattern
      • Buyback of shares
      • Share Performance
      • Financial Highlights
      • Notice of Board Meetings
      • General Meetings
      • Dividend Record
      • Scheme of Arrangements
      • Unpaid Dividend Account Details
      • Registrar and Share Transfer Agent
      • Contact Details for Investor Grievance Redressal
    • Corporate Governance
      • Board of Directors
      • Governance Policies
      • Code of Conduct
      • Code of Practices and Procedures for Fair Disclosure
      • Appointment and Resignation of Directors
      • Contact Details of KMPs
      • IR Contacts
    • Disclosures Under Regulation 46
      • Disclosures under Regulation 46 of the LODR
  • Media
    • Press Releases
    • Corporate Kit
  • Careers
    • Our Culture & Values
    • Life @ Aurobindo
    • Work with us / Oppurtunities
  • Contact Us

Investors

Commitment towards creating consistent value for our shareholders

Credit Rating

Rating Letter Aurobindo Pharma March 2025

PDF icon

Rating Letter Aurobindo Pharma – December 2023

PDF icon

Rating Letter Aurobindo Pharma – October 2022

PDF icon

Rating letter Aurobindo Pharma - August 2021

PDF icon

Rating letter Aurobindo Pharma - July 2020

PDF icon

Rating letter Aurobindo Pharma - October 2019

PDF icon

Rating Letter Aurobindo Pharma September 2018

PDF icon

India Ratings Places Aurobindo Pharma on RWP

PDF icon

Rating letter Aurobindo Pharma May 2018

PDF icon
Footer Logo

REGISTERED OFFICE

Plot no. 2, Maitrivihar, Ameerpet, Hyderabad-500038, Telangana, India.

CORPORATE OFFICE

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City,
Raidurg Panmaktha, Rangareddy District,
Hyderabad - 500032, Telangana, India.

  • About Us
  • Our Business
  • Sustainability
  • Investors
  • Media
  • Careers
  • Contact Us
  • Privacy Policy
  • Site Map

© Copyright 2025 Aurobindo Pharma Limited. All rights reserved.